Skip to main content
BMA
NYSE Finance

Macro Bank Reports Strong Q1 2026 Net Income Rebound and Efficiency Gains Amid Rising Non-Performing Loans

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
8
Price
$85.26
Mkt Cap
$5.337B
52W Low
$38.3
52W High
$106.15
Market data snapshot near publication time

Summary

Macro Bank Inc. announced strong first-quarter 2026 financial results, with net income up 131% year-over-year and improved efficiency, though asset quality deteriorated with a rise in non-performing loans.


Key Events

  • Significant Net Income Rebound

    Net income for Q1 2026 totaled Ps. 139.8 billion, marking a 28% increase quarter-over-quarter and a 131% increase year-over-year, reversing the decline seen in 2025.

  • Improved Operational Efficiency

    The efficiency ratio improved to 32% from 38.7% in 4Q25, supported by a 3% reduction in headcount and the closure of 24 branches.

  • Deterioration in Asset Quality

    The non-performing to total financing ratio increased to 5.40% in Q1 2026, up from 3.87% in 4Q25, indicating a significant rise in problematic loans.

  • Restructuring Expenses Recorded

    The bank recorded Ps. 19.9 billion (Ps. 12.9 billion after tax) in restructuring expenses related to early retirement plans and severance payments.


Analysis

Macro Bank Inc. reported a significant rebound in net income for the first quarter of 2026, reaching Ps. 139.8 billion, a 131% increase year-over-year. This strong performance follows a 32% decline in net income for the full year 2025, as previously reported in the 20-F filing on April 20, 2026. The bank also demonstrated improved operational efficiency, with its efficiency ratio improving to 32% from 38.7% in the prior quarter, driven by cost-cutting measures including a 3% reduction in headcount and the closure of 24 branches. However, a notable concern is the deterioration in asset quality, with the non-performing to total financing ratio increasing significantly to 5.40% from 3.87% in the fourth quarter of 2025, indicating potential future credit loss risks.

At the time of this filing, BMA was trading at $85.26 on NYSE in the Finance sector, with a market capitalization of approximately $5.3B. The 52-week trading range was $38.30 to $106.15. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BMA - Latest Insights

BMA
May 27, 2026, 5:07 PM EDT
Filing Type: 6-K
Importance Score:
8
BMA
May 27, 2026, 4:39 PM EDT
Filing Type: 6-K
Importance Score:
8
BMA
May 20, 2026, 10:57 AM EDT
Filing Type: 6-K
Importance Score:
7
BMA
May 06, 2026, 4:26 PM EDT
Filing Type: 6-K
Importance Score:
8
BMA
Apr 20, 2026, 3:48 PM EDT
Filing Type: 20-F
Importance Score:
9
BMA
Apr 08, 2026, 11:42 AM EDT
Filing Type: 6-K
Importance Score:
7
BMA
Mar 20, 2026, 4:23 PM EDT
Filing Type: 6-K
Importance Score:
8
BMA
Mar 20, 2026, 9:10 AM EDT
Filing Type: 6-K
Importance Score:
7
BMA
Mar 09, 2026, 4:14 PM EDT
Filing Type: 6-K
Importance Score:
7
BMA
Feb 25, 2026, 4:51 PM EST
Filing Type: 6-K
Importance Score:
8